Fenquizone
Fenquizone
|
Systematic (IUPAC) name |
---|
7-chloro-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinazoline-6-sulfonamide |
Clinical data |
---|
Identifiers |
---|
|
C03BA13 |
---|
PubChem |
CID 68548 |
---|
ChemSpider |
61822 Y |
---|
UNII |
LJ1U13R8IK Y |
---|
KEGG |
D04161 Y |
---|
Chemical data |
---|
Formula |
C14H12ClN3O3S |
---|
|
337.781 g/mol |
---|
SMILES
- O=S(=O)(c3c(Cl)cc2c(C(=O)NC(c1ccccc1)N2)c3)N
|
InChI=1S/C14H12ClN3O3S/c15-10-7-11-9(6-12(10)22(16,20)21)14(19)18-13(17-11)8-4-2-1-3-5-8/h1-7,13,17H,(H,18,19)(H2,16,20,21)
Y
Key:DBDTUXMDTSTPQZ-UHFFFAOYSA-N
Y
|
Y (what is this?) (verify) |
---|
Fenquizone (INN) is a diuretic, part of the class of low-ceiling sulfonamide diuretics. Fenquizone is used primarily in the treatment of oedema and hypertension. [1]
See also
References
|
---|
| Sulfonamides (and etacrynic acid) | |
---|
| Potassium-sparing (at CD) | |
---|
| Osmotic diuretics (PT, DL) | |
---|
| Vasopressin receptor antagonists (DCT and CD) | |
---|
| Other | |
---|
| |
---|
| Description |
- Anatomy
- Arteries
- head and neck
- arms
- chest
- abdomen
- legs
- Veins
- head and neck
- arms
- chest
- abdomen and pelvis
- legs
- Development
- Cells
- Physiology
|
---|
| Disease |
- Congenital
- Neoplasms and cancer
- Lymphatic vessels
- Injury
- Vasculitis
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- beta blockers
- channel blockers
- diuretics
- nonsympatholytic vasodilatory antihypertensives
- peripheral vasodilators
- renin–angiotensin system
- sympatholytic antihypertensives
- vasoprotectives
|
---|
|
|